Experts with AIR will present a variety of education research and finance sessions during the 46th annual Association for Education Finance and Policy (AEFP) conference, taking place virtually March 17-20, 2021. This year’s conference theme is “Promoting Equity and Opportunity Through Education Policy Research,” and is designed to facilitate collaborations ...
Very little is known about what resources are required to operate high-quality Out-of-School Time (OST) programs. The purpose of this study is to develop timely and relevant estimates of OST program costs and the funding necessary to support high-quality OST programs. AIR will use state-of-the-field methods for determining education program ...
Robert Nathenson is a senior researcher at AIR. He has over 10 years of experience in the execution of rigorous econometric and behavioral science techniques to applied policy questions in the postsecondary education, pre-k-12 education, and health fields. Dr. Nathenson regularly conducts research using both experimental and quasi-experimental designs. His ...
Tammy Kolbe is a principal researcher at AIR, specializing in evaluating the resources and costs associated with effectively implementing policies and programs in PK-16 educational organizations. A particular focus of her work has been funding and costs for special education programs for children with disabilities, having led multiple projects that ...
In this AIR Equity Initiative-funded study, we examined how full pcHPSA designation impacted the supply of health care providers to the area, and assessed if the financial and immigration visa incentives are effective in attracting primary care providers to practice in designated counties.
The Funding Formula Study Task Force (FFSTF), appointed by the New Mexico State Legislature and the Governor, and under the direction of the Legislative Council Service, commissioned AIR to conduct a comprehensive study on the current New Mexico public school funding formula.
Biological drugs, or biologics, are innovative therapies for people with debilitating and life-threatening diseases; but these drugs are expensive. In this Q&A, AIR’s Thiyagu Rajakannan, senior researcher and lead for Drug Coverage and Payment Practice in the Health Division at AIR, explains how lower-cost versions of these drugs and promising ...
This spotlight takes a look at the history of Title I, how the program has changed over time, and how it affects children, schools, families and education policy. Experts weigh in on the program's past and future in interviews, briefs, and blogs.